Literature DB >> 7770499

The use of ultrasound as an enhancer for transcutaneous drug delivery: phonophoresis.

N N Byl1.   

Abstract

Phonophoresis is the use of ultrasound (US) to enhance the delivery of topically applied drugs. The purposes of this article are (1) to review the basic principles of transcutaneous drug delivery, (2) to summarize the functional anatomy of the skin pertinent to phonophoresis, (3) to outline the physiological principles of US as an enhancer of topically applied drugs, (4) to review the literature on the efficacy of phonophoresis, (5) to discuss the relevance of US as an enhancer of topical drugs in the practice of physical therapy, and (6) to outline areas of needed research. Seventy-five percent of the studies reviewed reported positive effects of US on local subcutaneous drug diffusion, but some systemic effects were reported. This research review indicates that to maximize the clinical effectiveness of phonophoresis: (1) the topical drug (both the drug and the carrying agent) should transmit US; (2) the skin should be pretreated with US, heating, moistening, or shaving; (3) the patient needs to be positioned to maximize circulation during treatment; (4) a dressing that seals the area and prevents the escape of moisture should be applied after treatment; (5) an intensity of 1.5 W/cm2 should be used to capture both the thermal and nonthermal effects of the US; and (6) low-intensity US (0.5 W/cm2) should be used when treating open wounds or acute injuries. Research is needed to clarify what parameters of US will most efficiently facilitate topical drug diffusion, how often and for what duration US should be used to maximize local absorption of drugs, and which topical drugs can most effectively be used for phonophoresis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7770499     DOI: 10.1093/ptj/75.6.539

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  29 in total

1.  Intramuscular Temperature Rises With Topical Analgesics Used as Coupling Agents During Therapeutic Ultrasound.

Authors:  J William Myrer; Gary J. Measom; Gilbert W. Fellingham
Journal:  J Athl Train       Date:  2001-03       Impact factor: 2.860

Review 2.  Testosterone hormone replacement therapy: state-of-the-art and emerging technologies.

Authors:  Marie-Laure Leichtnam; Hervé Rolland; Patrick Wüthrich; Richard H Guy
Journal:  Pharm Res       Date:  2006-06-09       Impact factor: 4.200

3.  Sonophoresis-mechanisms and application.

Authors:  Edina Vranić
Journal:  Bosn J Basic Med Sci       Date:  2004-05       Impact factor: 3.363

Review 4.  Ultrasonic drug delivery--a general review.

Authors:  William G Pitt; Ghaleb A Husseini; Bryant J Staples
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

5.  Temperature rise in human muscle during ultrasound treatments using flex-all as a coupling agent.

Authors:  D F Ashton; D O Draper; J W Myrer
Journal:  J Athl Train       Date:  1998-04       Impact factor: 2.860

6.  Cortisol concentrations in human skeletal muscle tissue after phonophoresis with 10% hydrocortisone gel.

Authors:  Amanda R Kuntz; Christine M Griffiths; James M Rankin; Charles W Armstrong; Thomas J McLoughlin
Journal:  J Athl Train       Date:  2006 Jul-Sep       Impact factor: 2.860

7.  Comparison the efficacy of phonophoresis and ultrasound therapy in myofascial pain syndrome.

Authors:  Saime Ay; Sebnem Koldaş Doğan; Deniz Evcik; Ozgün Cakmak Başer
Journal:  Rheumatol Int       Date:  2010-03-31       Impact factor: 2.631

8.  Topical drug delivery in humans with a single photomechanical wave.

Authors:  S Lee; N Kollias; D J McAuliffe; T J Flotte; A G Doukas
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

9.  The role of phonophoresis in dyshpagia due to cervical osteophytes.

Authors:  Zeliha Unlu; Sebnem Orguc; Gorkem Eskiizmir; Asim Aslan; Saliha Tasci
Journal:  Int J Gen Med       Date:  2008-11-30

10.  Is phonophoresis effective in the treatment of chronic low back pain? A single-blind randomized controlled trial.

Authors:  Dilek Durmus; Gamze Alayli; Ahmet Salim Goktepe; Mehmet Ali Taskaynatan; Ayhan Bilgici; Omer Kuru
Journal:  Rheumatol Int       Date:  2013-01-03       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.